Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$59 Mln
Revenue (TTM)
$322 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.9 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.5
Industry P/E
--
EV/EBITDA
5.6
Div. Yield
0 %
Debt to Equity
0
Book Value
$1454665
EPS
$-1.8
Face value
--
Shares outstanding
98,750,251
CFO
$-62.16 Mln
EBITDA
$57.40 Mln
Net Profit
$29.15 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
DocGo (DCGO)
| -35.1 | -20.6 | -35.1 | -78.7 | -59.6 | -43.5 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
DocGo (DCGO)
| -79.3 | -24.0 | -20.9 | -24.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
DocGo (DCGO)
|
0.6 | 59.2 | 322.2 | -182.4 | -27.8 | -0 | -- | 0.5 |
| 14.0 | 3,186.8 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 380.6 | 5,278.0 | 2,530.0 | 265.2 | 14.2 | 25.3 | 20.1 | 5.3 | |
| 54.5 | 2,778.6 | 941.5 | 105.7 | 14.5 | 29.4 | 26.2 | 7.3 | |
| 97.4 | 9,812.1 | 5,935.2 | 566.2 | 18.1 | 25.1 | 17.6 | 3.9 | |
| 19.1 | 4,280.7 | 2,347.6 | 128.4 | 4.5 | 25.2 | 36.8 | 7.9 | |
| 27.5 | 4,285.8 | 5,649.5 | 207.6 | 7.0 | 15.2 | 21.3 | 3.3 | |
| 54.8 | 4,326.1 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.0 | |
| 15.0 | 3,768.2 | 1,163.6 | 78.0 | 26.1 | 15.4 | 49.1 | 6.2 | |
| 196.6 | 11,646.4 | 5,057.8 | 344.0 | 9.2 | 16.9 | 34.4 | 5.2 |
DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency... response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, monitoring and care management, procedures, point-of-care tests, and screenings and coaching; event services, including on-site healthcare support at sporting events and concerts; virtual care management; and remote patient monitoring and chronic disease management services. The company serves municipalities, hospitals and health systems, states and communities, insurers, physician practices, health plans, and businesses and employees. DocGo Inc. was founded in 2015 and is headquartered in New York, New York. Address: 685 Third Avenue, New York, NY, United States, 10017 Read more
CEO & Director
Mr. Lee Bienstock
CEO & Director
Mr. Lee Bienstock
Headquarters
New York, NY
Website
The share price of DocGo Inc (DCGO) is $0.57 (NASDAQ) as of 02-Apr-2026 16:00 EDT. DocGo Inc (DCGO) has given a return of -59.61% in the last 3 years.
Since, TTM earnings of DocGo Inc (DCGO) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.48
|
0.00
|
|
2024
|
23.12
|
1.44
|
|
2023
|
86.40
|
1.97
|
|
2022
|
21.06
|
2.67
|
|
2021
|
37.41
|
3.91
|
The 52-week high and low of DocGo Inc (DCGO) are Rs 2.76 and Rs 0.55 as of 03-Apr-2026.
DocGo Inc (DCGO) has a market capitalisation of $ 59 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in DocGo Inc (DCGO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.